Hospital General Universitario de Alicante -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome

    Journal of Clinical Lipidology, Vol. 17, Núm. 6, pp. 756-764

2021

  1. Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI study

    Clinica e Investigacion en Arteriosclerosis, Vol. 33, Núm. 6, pp. 296-305

  2. Chronic coronary syndrome: Overcoming clinical practice guidelines. the role of the compass strategy

    Current Cardiology Reviews, Vol. 17, Núm. 3, pp. 364-375

  3. Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 118-128

2020

  1. First national registry of evolocumab in clinical practice in cardiology units in Spain. The RETOSS-CARDIO study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 513-515

  2. First national registry on the effectiveness and safety of evolocumab in clinical practice in patients attended in cardiology in Spain. The RETOSS-CARDIO study

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 6, pp. 231-241

  3. Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 2, pp. 161-167